402 filings
Page 4 of 21
6-K
nrgmiyar5
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
tl7qf6jrji
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
k1fji pa9juh5nh1
23 Jun 22
Current report (foreign)
11:01am
6-K
zlf o1e2cpk
2 Jun 22
Galapagos receives transparency notification from FMR LLC
6:00am
6-K
l4iu au666d6z9xb07xc
31 May 22
Current report (foreign)
1:39pm
6-K
pjyqvzsui lg994oeq7
11 May 22
Current report (foreign)
4:05pm
6-K
ilp7csb
9 May 22
Galapagos creates new subscription right plans
11:54am
6-K
vj2qncnu m1otc2ngpno
6 May 22
Current report (foreign)
5:18pm
6-K
fx1be6
28 Apr 22
Current report (foreign)
4:06pm
6-K
d0ehuh 4a315
27 Apr 22
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
6:00am
6-K
05ki53w qji
11 Apr 22
Current report (foreign)
5:14pm
6-K
8ts09h zj3yo
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
dp1wh8g insgsay0hsa
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
8jg1ke7
24 Mar 22
Current report (foreign)
9:51am
6-K
ha9w0
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
iccntmp 0vs
7 Feb 22
Galapagos receives transparency notification from EcoR1 Capital
2:40pm
6-K
ptaevdzgi
7 Feb 22
Current report (foreign)
2:40pm
6-K
3wi0glcc9fbh04m
27 Jan 22
Galapagos appoints Paul Stoffels as Chief Executive Officer
12:00am
6-K
brbnca2n57gun0ukzv
26 Jan 22
Galapagos creates new subscription right plan
5:30pm